IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $214,000 | 0.0% | 3,536 | -1.1% | 0.01% | -16.7% |
Q3 2019 | $214,000 | -6.1% | 3,576 | +1.0% | 0.01% | +9.1% |
Q2 2019 | $228,000 | -2.1% | 3,541 | -18.0% | 0.01% | -35.3% |
Q4 2018 | $233,000 | +4.5% | 4,316 | 0.0% | 0.02% | +41.7% |
Q3 2018 | $223,000 | -98.3% | 4,316 | -98.4% | 0.01% | -97.3% |
Q4 2016 | $13,101,000 | +30.5% | 273,900 | 0.0% | 0.45% | +36.8% |
Q3 2016 | $10,036,000 | +57.3% | 273,900 | 0.0% | 0.33% | +41.2% |
Q2 2016 | $6,379,000 | -33.3% | 273,900 | +16.1% | 0.23% | -33.0% |
Q1 2016 | $9,558,000 | -27.2% | 236,000 | +11.3% | 0.35% | -23.0% |
Q4 2015 | $13,129,000 | – | 212,000 | – | 0.45% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 6,913,172 | $330,657,000 | 12.25% |
TANAKA CAPITAL MANAGEMENT INC | 84,953 | $4,063,000 | 9.51% |
Sicart Associates LLC | 280,315 | $13,407,000 | 9.26% |
DOWLING & YAHNKE LLC | 675,843 | $32,326,000 | 3.62% |
Opus Point Partners Management, LLC | 77,550 | $3,709,000 | 2.96% |
Motley Fool Asset Management LLC | 259,000 | $12,388,000 | 2.75% |
Motley Fool Wealth Management, LLC | 333,604 | $15,956,000 | 1.70% |
ALTRINSIC GLOBAL ADVISORS LLC | 921,174 | $44,060,000 | 1.63% |
PINNACLE ASSOCIATES LTD | 1,572,045 | $75,191,000 | 1.52% |
Sonora Investment Management, LLC | 121,703 | $5,821,054,000 | 1.20% |